Boulder, CO, United States of America

Kenneth G Draper


Average Co-Inventor Count = 2.1

ph-index = 18

Forward Citations = 1,022(Granted Patents)


Location History:

  • Richmond, OH (US) (1997)
  • San Marcos, CA (US) (1993 - 2001)
  • Solon, OH (US) (1997 - 2001)
  • Boulder, CO (US) (1995 - 2003)

Company Filing History:


Years Active: 1993-2003

Loading Chart...
43 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Kenneth G. Draper

Introduction

Kenneth G. Draper is a prominent inventor based in Boulder, CO, recognized for his significant contributions to the field of biotechnology. With an impressive portfolio of 43 patents, Draper has focused on innovative methods for treating various cancers through the manipulation of gene expression.

Latest Patents

Among his latest patents, Draper has developed a method and reagent for the treatment of diseases by the expression of the c-Myc gene. This innovation involves an enzymatic RNA molecule that cleaves mRNA associated with the development or maintenance of Burkitt's lymphoma or acute lymphocytic leukemia. Additionally, he has patented a method and reagent for the treatment of lung cancer and other malignancies caused by the deregulation of L-MYC gene expression, also utilizing an enzymatic RNA molecule to target mRNA related to lung cancer.

Career Highlights

Throughout his career, Kenneth G. Draper has made significant strides in the biotech sector. He has held key roles at leading companies, including Ribozyme Pharmaceuticals, Incorporated and Isis Pharmaceuticals, Inc., where he has been instrumental in advancing research and development in therapeutic RNA technologies.

Collaborations

Draper's innovative work has not only been influenced by his own research but also through collaboration with esteemed colleagues such as James A. McSwiggen and Dan T. Stinchcomb. These partnerships have greatly contributed to the evolution of his groundbreaking projects in cancer treatment and gene therapy.

Conclusion

Kenneth G. Draperk continues to be a leading figure in the field of biotechnology, with a clear commitment to addressing complex medical challenges through innovative inventions. His patents and collaborations reflect a deep understanding of cancer biology, positioning him as a valuable contributor to the advancement of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…